Zimmer Biomet Holdings, Inc. Reports Third Quarter 2015 Financial Results

Go back to Zimmer Biomet Holdings, Inc. Reports Third Quarter 2015 Financial Results

Leerink Partners Remains Bullish on Zimmer Biomet Holdings (ZBH) Following an In-Line 3Q

October 30, 2015 11:54 AM EDT

Leerink Partners maintained an Outperform rating on Zimmer Holdings (NYSE: ZBH), and cut the price target to $125.00 (from $130.00), following the company's 3Q earnings results. 3Q revenues of $1.76B was in-line with consensus, along with of $1.64.

Analyst Richard Newitter commented, "Expectations were low, but ZBH's 3Q... More

Zimmer Biomet Holdings (ZBH) Tops Q3 EPS by 8c; Boosts FY15 EPS Outlook

October 29, 2015 7:41 AM EDT

Zimmer Biomet Holdings (NYSE: ZBH) reported Q3 EPS of $1.64, $0.08 better than the analyst estimate of $1.56. Revenue for the quarter came in at $1.76 billion versus the consensus estimate of $1.76 billion.

Zimmer Biomet Holdings sees FY2015 EPS of $6.83-$6.87, versus prior guidance of $6.65-$6.80 and... More